About
Intracept by Boston Scientific, operating under Relievant Medsystems, specializes in the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain linked to vertebral endplate damage. The company offers the Intracept™ Procedure, a minimally invasive outpatient treatment that targets and ablates the basivertebral nerve (BVN) to alleviate pain signals. Founded in 2006, Relievant Medsystems is committed to transforming vertebrogenic pain management through scientific research and clinical innovation. The Intracept Procedure is supported by advanced access instruments and has been validated through extensive clinical trials, demonstrating significant pain relief and functional improvement. The company also provides reimbursement support and training for healthcare professionals, ensuring effective adoption of the procedure in clinical settings. Intracept aims to improve the quality of life for patients suffering from chronic low back pain by delivering evidence-based solutions and fostering a culture of clinical excellence and innovation.
Technologies
Keywords
Company Information
- Employees210
- Founded2006
- Annual Revenue$70000000
- Total Funding$270664015
Location
7201 Metro Blvd, Minneapolis, Minnesota, United States, 55439-1300
